Search

Leah H. Schlientz

Examiner (ID: 5396)

Most Active Art Unit
1618
Art Unit(s)
1618
Total Applications
804
Issued Applications
283
Pending Applications
116
Abandoned Applications
429

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16977562 [patent_doc_number] => 20210221799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => AGGREGATION-INDUCED EMISSION LUMINOGENS FOR PHOTODYNAMIC THERAPY [patent_app_type] => utility [patent_app_number] => 17/248340 [patent_app_country] => US [patent_app_date] => 2021-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12431 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 337 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17248340 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/248340
Aggregation-induced emission luminogens for photodynamic therapy Jan 20, 2021 Issued
Array ( [id] => 16976254 [patent_doc_number] => 20210220491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => FLUORESCENCE IMAGING METHOD AND SYSTEM [patent_app_type] => utility [patent_app_number] => 17/150488 [patent_app_country] => US [patent_app_date] => 2021-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3762 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17150488 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/150488
FLUORESCENCE IMAGING METHOD AND SYSTEM Jan 14, 2021 Abandoned
Array ( [id] => 17020960 [patent_doc_number] => 20210244831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-12 [patent_title] => POLYDOPAMINE DECORATED TOBACCO MOSAIC THERANOSTIC VIRUS NANOPARTICLES [patent_app_type] => utility [patent_app_number] => 17/129490 [patent_app_country] => US [patent_app_date] => 2020-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12158 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17129490 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/129490
Polydopamine decorated tobacco mosaic theranostic virus nanoparticles Dec 20, 2020 Issued
Array ( [id] => 16776640 [patent_doc_number] => 20210113717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => MRI CONTRAST AGENT INCLUDING T1 CONTRAST MATERIAL COATED ON SURFACE OF NANOPARTICLE SUPPORT [patent_app_type] => utility [patent_app_number] => 17/126340 [patent_app_country] => US [patent_app_date] => 2020-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6829 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 181 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17126340 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/126340
MRI contrast agent including T1 contrast material coated on surface of nanoparticle support Dec 17, 2020 Issued
Array ( [id] => 18075977 [patent_doc_number] => 20220401589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-22 [patent_title] => PRE-TARGETING IMAGING AGENTS [patent_app_type] => utility [patent_app_number] => 17/777182 [patent_app_country] => US [patent_app_date] => 2020-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4324 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17777182 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/777182
PRE-TARGETING IMAGING AGENTS Dec 3, 2020 Pending
Array ( [id] => 17126110 [patent_doc_number] => 20210300878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-30 [patent_title] => CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING [patent_app_type] => utility [patent_app_number] => 17/111953 [patent_app_country] => US [patent_app_date] => 2020-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29053 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17111953 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/111953
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING Dec 3, 2020 Abandoned
Array ( [id] => 16853590 [patent_doc_number] => 20210154335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-27 [patent_title] => DYE AGGREGATES-CONTAINING NANOPARTICLES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/104859 [patent_app_country] => US [patent_app_date] => 2020-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47800 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17104859 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/104859
DYE AGGREGATES-CONTAINING NANOPARTICLES AND USES THEREOF Nov 24, 2020 Abandoned
Array ( [id] => 17154966 [patent_doc_number] => 20210316017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-14 [patent_title] => PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 17/103366 [patent_app_country] => US [patent_app_date] => 2020-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6736 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17103366 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/103366
PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF CANCER Nov 23, 2020 Abandoned
Array ( [id] => 18108146 [patent_doc_number] => 20230001026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-05 [patent_title] => PHARMACEUTICAL PACKAGING UNITS AND METHODS FOR CONCOMITANT ADMINISTRATION OF RADIOTRACERS [patent_app_type] => utility [patent_app_number] => 17/778754 [patent_app_country] => US [patent_app_date] => 2020-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9687 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17778754 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/778754
PHARMACEUTICAL PACKAGING UNITS AND METHODS FOR CONCOMITANT ADMINISTRATION OF RADIOTRACERS Nov 19, 2020 Pending
Array ( [id] => 16656115 [patent_doc_number] => 20210052751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-25 [patent_title] => Ultrasound Gel Composition [patent_app_type] => utility [patent_app_number] => 17/093155 [patent_app_country] => US [patent_app_date] => 2020-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1994 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17093155 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/093155
Ultrasound Gel Composition Nov 8, 2020 Abandoned
Array ( [id] => 18056549 [patent_doc_number] => 20220387635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => PET IMAGING OF CANCEROUS CELLS USING 18F-FLUOROACETATE [patent_app_type] => utility [patent_app_number] => 17/774136 [patent_app_country] => US [patent_app_date] => 2020-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7149 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17774136 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/774136
PET IMAGING OF CANCEROUS CELLS USING 18F-FLUOROACETATE Nov 3, 2020 Pending
Array ( [id] => 18019146 [patent_doc_number] => 20220370645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-24 [patent_title] => METHOD, DEVICE AND MARKER SUBSTANCE KIT FOR MULTI-PARAMETRIC X-RAY FLUORESCENCE IMAGING [patent_app_type] => utility [patent_app_number] => 17/771460 [patent_app_country] => US [patent_app_date] => 2020-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13419 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17771460 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/771460
METHOD, DEVICE AND MARKER SUBSTANCE KIT FOR MULTI-PARAMETRIC X-RAY FLUORESCENCE IMAGING Oct 22, 2020 Pending
Array ( [id] => 18034734 [patent_doc_number] => 20220378949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-01 [patent_title] => NEUROTROPHIN RECEPTOR BINDING CONJUGATE COMPOSITIONS, METHODS OF USE AND METHODS OF MAKING THEREOF [patent_app_type] => utility [patent_app_number] => 17/769693 [patent_app_country] => US [patent_app_date] => 2020-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28799 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769693 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/769693
NEUROTROPHIN RECEPTOR BINDING CONJUGATE COMPOSITIONS, METHODS OF USE AND METHODS OF MAKING THEREOF Oct 21, 2020 Pending
Array ( [id] => 19125851 [patent_doc_number] => 20240131204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-25 [patent_title] => Fractionated Dosing of a Phospholipid Ether Analog for the Treatment of Cancer [patent_app_type] => utility [patent_app_number] => 17/768420 [patent_app_country] => US [patent_app_date] => 2020-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10422 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17768420 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/768420
Fractionated Dosing of a Phospholipid Ether Analog for the Treatment of Cancer Oct 8, 2020 Pending
Array ( [id] => 16596484 [patent_doc_number] => 20210023015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => COLOR-CODED AND SIZED LOADABLE POLYMERIC PARTICLES FOR THERAPEUTIC AND/OR DIAGNOSTIC APPLICATIONS AND METHODS OFPREPARING AND USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/065319 [patent_app_country] => US [patent_app_date] => 2020-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17415 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17065319 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/065319
Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same Oct 6, 2020 Issued
Array ( [id] => 18176931 [patent_doc_number] => 20230037660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => METHODS OF TREATING VASCULAR LESIONS AND MALFORMATIONS [patent_app_type] => utility [patent_app_number] => 17/764132 [patent_app_country] => US [patent_app_date] => 2020-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49168 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17764132 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/764132
METHODS OF TREATING VASCULAR LESIONS AND MALFORMATIONS Sep 30, 2020 Abandoned
Array ( [id] => 18108147 [patent_doc_number] => 20230001027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-05 [patent_title] => METAL CHELATING AGENTS AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/764708 [patent_app_country] => US [patent_app_date] => 2020-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29640 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17764708 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/764708
METAL CHELATING AGENTS AND METHODS OF USING THE SAME Sep 29, 2020 Pending
Array ( [id] => 16710490 [patent_doc_number] => 20210077637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-18 [patent_title] => PH and Oxygen dual-sensitive magnetic resonance imaging contrast agent and preparation method thereof [patent_app_type] => utility [patent_app_number] => 17/060059 [patent_app_country] => US [patent_app_date] => 2020-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3409 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17060059 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/060059
PH and Oxygen dual-sensitive magnetic resonance imaging contrast agent and preparation method thereof Sep 29, 2020 Abandoned
Array ( [id] => 20343121 [patent_doc_number] => 12466843 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-11 [patent_title] => Gadolinium-based compound, method for producing same, and MRI contrast agent containing same [patent_app_type] => utility [patent_app_number] => 17/755143 [patent_app_country] => US [patent_app_date] => 2020-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 916 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17755143 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/755143
Gadolinium-based compound, method for producing same, and MRI contrast agent containing same Sep 28, 2020 Issued
Array ( [id] => 18091406 [patent_doc_number] => 20220409747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-29 [patent_title] => FIBROBLAST ACTIVATION PROTEIN (FAP)-TARGETED IMAGING AND THERAPY OF CANCERS AND OTHER FIBROTIC AND INFLAMMATORY DISEASES [patent_app_type] => utility [patent_app_number] => 17/761508 [patent_app_country] => US [patent_app_date] => 2020-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24854 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761508 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/761508
FIBROBLAST ACTIVATION PROTEIN (FAP)-TARGETED IMAGING AND THERAPY OF CANCERS AND OTHER FIBROTIC AND INFLAMMATORY DISEASES Sep 16, 2020 Pending
Menu